Pentwater Capital Management LP
Q2 2020 13F-HR Holdings
Net value change ($000)
-440,211
(-7.3%)
New positions
56
Sold out positions
20
Turnover %
61.4%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| 58.com Inc. | 266,615 | NEW |
| TIFFANY & CO | 135,156 | 51.6% |
| CAESARS HOLDINGS, INC. | 101,074 | 214.1% |
| VICI | 96,214 | 2482.9% |
| PCG | 96,089 | 49.6% |
| LEGG MASON, INC. | 68,877 | 72.3% |
| TURQUOISE HILL RESOURCES LTD | 66,081 | 94.6% |
| Delphi Technologies PLC | 59,064 | 1503.3% |
| TAUBMAN CENTERS INC | 53,848 | 64.3% |
| SPY | 51,616 | 17.8% |
Top Reduces (Value $000, Stocks/ETFs)
| MELLANOX TECHNOLOGIES LTD | -374,573 | -100.0% |
| Allergan plc | -300,015 | -100.0% |
| CYPRESS SEMICONDUCTOR CORP /DE/ | -255,803 | -100.0% |
| Forty Seven, Inc. | -142,596 | -100.0% |
| WABCO Holdings Inc. | -127,370 | -100.0% |
| SPRINT CORPORATION | -108,172 | -100.0% |
| TECH DATA CORP | -80,316 | -100.0% |
| BA | -75,566 | -94.9% |
| ANIXTER INTERNATIONAL INC | -60,181 | -100.0% |
| Ra Pharmaceuticals, Inc. | -46,987 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
2,265,012
(40.3% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|